Clifton Fuller, MD
Radiation Oncology · Houston, TXNPI 1821279191
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Elekta, Inc. at 42.6% of the total. Reporting peaked in 2024 at $3,347 and has fallen 93.9% since, to $204 in 2025.
Across 22 payments — averaging $385.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$4K
- Siemens Medical Solutions USA, Inc.$4K
- Raysearch Laboratories AB (publ)$485
- Elekta Medical Systems India Pvt Ltd$387
- Elekta LTD$234
- Telix Pharmaceuticals$128
- plus $124 from 2 others
Across 18 payments — averaging $88,283 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elekta Limited$1.6M
- Philips North America LLC$21K
- Elekta, Inc.$16K
What the payments were for
- Consulting fees$1,57519%
- Speaking & faculty fees$4,22550%
- Travel & lodging$96211%
- Food & beverage$1,62019%
- Entertainment$911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 8 | $3,608 |
| Siemens Medical Solutions USA, Inc. | 8 | $3,504 |
| Raysearch Laboratories AB (publ) | 1 | $485 |
| Elekta Medical Systems India Pvt Ltd | 1 | $387 |
| Elekta LTD | 1 | $234 |
| Telix Pharmaceuticals | 1 | $128 |
| Teleflex LLC | 1 | $79 |
| GE HealthCare | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAGNETOM Free.Max$2,725
- Mosaiq$1,575
- Unity$1,500
- ELEKTA MEDICAL LINEAR ACCELERATOR$802
- ILLUCCIX$257
- Varian Treatment$200
- ELEKTA UNITY$167
How this compares
$8,472 in reported general payments places this provider in the 85th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 13 | $1,849 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Houston
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Abhilasha PatelHouston$76K
- Joe ChangHouston$50K
- Daniel GomezHouston$47K
- David RosenthalHouston$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.